Sofinnova: At the Intersection of Life Science, Finance & Innovation
Since our founding in 1974, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade. We are a clinical-stage biopharmaceutical investment firm with approximately $2.2B in assets under management and committed capital.* We invest in both private and public equity of therapeutics-focused companies.
Our Mission: to improve the lives of patients through science. We strive to provide outstanding results for those we serve: patients, entrepreneurs, and the investors that entrust us with their capital.